Diagnostic and Prognostic Value of Presepsin for Subclinical Chorioamnionitis in Pregnancies between 23-28 Week with Preterm Premature Rupture of the Membranes

Year 2016, Volume: 33 Issue: 6, 668 - 674, 01.11.2016

Erbil Çakar Şule Eren Çakar Habibe Ayvacı Taşan Deniz Karçaaltıncaba Mehmet Baki Şentürk Nermin Koç Ramazan Uluhan

Abstract

Background: Presepsin is an inflammatory marker released from monocytes and macrophages as an acute reaction to microbial infection. We hypothesized that it may be useful in pregnancies with preterm premature rupture of the membranes (PPROM) for early diagnosis of subclinical chorioamnionitis. Aims: To determine whether the plasma presepsin level has any diagnostic or prognostic value for subclinical chorioamnionitis in pregnancies complicated with PPROM. Study Design: Prospective cohort study. Methods: Fifty-three singleton pregnancies between 23 and 28 weeks of gestation diagnosed with PPROM were prospectively included in the study. Venous blood samples were collected at admission, at the 48th hour of admission, and at the time of delivery to determine presepsin and C-reactive Protein (CRP) levels and white blood cell (WBC) counts. Chorioamnionitis was diagnosed by microscopic examination of the placenta and cords. Results: Of the 53 PPROM cases included in the study, 41 (77.4%) had histologically confirmed chorioamnionitis. Neonatal sepsis developed in 24 (45.3%) of the newborns. The median presepsin level at admission was 135.0 pg/mL for pregnancies with subclinical chorioamnionitis and 113.5pg/mL for pregnancies without chorioamnionitis (p=0.573). There was also no significant difference between subclinical chorioamnionitis (+) and (−) cases in terms presepsin levels at the 48th hour and at delivery. However, chorioamnionitis (+) cases showed a significant decrease in both presepsin level and WBC count at the 48th hour after the administration of antibiotics, which increased significantly at delivery (p<0.001 and p=0.011, respectively). Conclusion: The striking fluctuations in presepsin level after the diagnosis of PPROM can be used to predict subclinical chorioamnionitis and determine the optimal timing of delivery before the clinical signs of chorioamnionitis are established. However, presepsin level itself was neither diagnostic nor prognostic for neonatal sepsis.

Keywords

Premature rupture of the membranes, preterm, chorioamnionitis, neonatal sepsis

References

• 1. Ecevit A, Anuk-İnce D, Yapakçı E, Kupana-Ayva Ş, Kurt A, Yanık FF, et al. Association of respiratory distress syndrome and perinatal hypoxia with histologic chorioamnionitis in preterm infants. Turk J Pediatr 2014;56:56-61.
• 2. Romero R, Espinoza J, Kusanovic JP, Gotsch F, Hassan S, Erez O, et al. The preterm parturition syndrome. BJOG 2006;113 (Suppl 3):17-42. [CrossRef]
• 3. Noor S, Nazar AF, Bashir R, Sultana R. Prevalence of PPROM and its outcome. J Ayub Med Coll Abbottabad 2007;19:14-7.
• 4. Dempsey E, Chen MF, Kokottis T, Vallerand D, Usher R. Outcome of neonates less than 30 weeks gestation with histologic chorioamnionitis. Am J Perinatol 2005;22:155-9. [CrossRef]
• 5. Dexter SC, Pinar H, Malee MP, Hogan J, Carpenter MW, Vohr BR. Outcome of very low birth weight infants with histopathologic chorioamnionitis. Obstet Gynecol 2000;96:172-7. [CrossRef]
• 6. Lahra MM, Beeby PJ, Jeffery HE. Intrauterine inflammation, neonatal sepsis, and chronic lung disease: a 13-year hospital cohort study. Pediatrics 2009;123:1314-9. [CrossRef]
• 7. Hendson L, Russell L, Robertson CM, Liang Y, Chen Y, Abdalla A, et al. Neonatal and neurodevelopmental outcomes of very low birth weight infants with histologic chorioamnionitis. J Pediatr 2011;158:397-402. [CrossRef]
• 8. Thomas W, Speer CP. Chorioamnionitis: important risk factor or innocent bystander for neonatal outcome? Neonatology 2011;99:177-87. [CrossRef]
• 9. Gibbs RS, Blanco JD, St Clair PJ, Castaneda YS. Quantitative bacteriology of amniotic fluid from women with clinical intraamniotic infection at term. J Infect Dis 1982;145:1-8. [CrossRef]
• 10. Edwards RK. Chorioamnionitis and labor. Obstet Gynecol Clin North Am 2005;32:287-96. [CrossRef]
• 11. Miyazaki K, Furuhashi M, Matsuo K, Minami K, Yoshida K, Kuno N, et al. Impact of subclinical chorioamnionitis on maternal and neonatal outcomes. Acta Obstet Gynecol Scand 2007;86:191-7. [CrossRef]
• 12. Behnes M, Bertsch T, Lepiorz D, Lang S, Trinkmann F, Brueckmann M, et al. Diagnostic and prognostic utility of soluble CD
• 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment. Crit Care 2014;18:507. [CrossRef]
• 13. Töllner U. Early diagnosis of septicemia in the newborn. Clinical studies and sepsis score. Eur J Pediatr 1982;138:331-7. [CrossRef]
• 14. Greene MF, Creasy RK, Resnik R, Iams JD, Lockwood CJ, Moore T. Creasy and Resnik’s Maternal-Fetal Medicine: Principles and Practice. 6th ed. Philadelphia, PA, USA: Elsevier Saunders; 2010.
• 15. Newton ER. Preterm labor, preterm premature rupture of membranes, and chorioamnionitis. Clin Perinatol 2005;32:571-600. [CrossRef]
• 16. Esteves JS, de Sá RA, de Carvalho PR, Coca Velarde LG. Neonatal outcome in women with preterm premature rupture of membranes (PPROM) between 18 and 26 weeks. J Matern Fetal Neonatal Med 2016;29:1108-12. [CrossRef]
• 17. Arora P, Bagga R, Kalra J, Kumar P, Radhika S, Gautam V. Mean gestation at delivery and histological chorioamnionitis correlates with early-onset neonatal sepsis following expectant management in pPROM. J Obstet Gynaecol 2015;35:235-40. [CrossRef]
• 18. Erdemir G, Kultursay N, Calkavur S, Zekioğlu O, Koroglu OA, Cakmak B, et al. Histological chorioamnionitis: effects on premature delivery and neonatal prognosis. Pediatr Neonatol 2013;54:267-74. [CrossRef]
• 19. Xie A, Zhang W, Chen M, Wang Y, Wang Y, Zhou Q, et al. Related factors and adverse neonatal outcomes in women with preterm premature rupture of membranes complicated by histologic chorioamnionitis. Med Sci Monit 2015;21:390-5. [CrossRef]
• 20. Giavarina D, Carta M. Determination of reference interval for presepsin, an early marker for sepsis. Biochem Med (Zagreb) 2015;25:64-8. [CrossRef]
• 21. Liu B, Chen YX, Yin Q, Zhao YZ, Li CS. Diagnostic value and prognostic evaluation of presepsin for sepsis in an emergency department. Crit Care 2013;17:R244. [CrossRef]
• 22. Endo S, Suzuki Y, Takahashi G, Shozushima T, Ishikura H, Murai A, et al. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. J Infect Chemother 2012;18:891- 7. [CrossRef]
• 23. Godnic M, Stubljar D, Skvarc M, Jukic T. Diagnostic and prognostic value of sCD14-ST-presepsin for patients admitted to hospital intensive care unit (ICU). Wien Klin Wochenschr 2015;127:521-7. [CrossRef]
• 24. Topcuoglu S, Arslanbuga C, Gursoy T, Aktas A, Karatekin G, Uluhan R, et al. Role of presepsin in the diagnosis of late-onset neonatal sepsis in preterm infants. J Matern Fetal Neonatal Med 2016;29:1834-9.
• 25. Çekmez Y, Çekmez F, Özkaya E, Pirgon Ö, Yılmaz Z, Yılmaz EA, et al. Proadrenomedullin and serum amyloid A as a predictor of subclinical chorioamnionitis in preterm premature rupture of membranes. J Interferon Cytokine Res 2013;33:694-9. [CrossRef]
• 26. Skrablin S, Lovric H, Banovic V, Kralik S, Dijakovic A, Kalafatic D. Maternal plasma interleukin-6, interleukin-1beta and C-reactive protein as indicators of tocolysis failure and neonatal outcome after preterm delivery. J Matern Fetal Neonatal Med 2007;20:335-41. [CrossRef]